$6.19
-0.14-2.21%
Last update: Nov 6, 4:00 PM

The average analyst price target for Embecta is $6.67, 7.8% above the current price. Of 4 analysts, 2 rate it Hold and 2 Sell. Targets range from $3 to $12. The latest change came on May 18, 2026, when B of A Securities lowered its price target on Embecta from $11 to $3 and kept an Underperform rating.
Price Target Range — 8 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months